Annual Total Liabilities
$568.19 M
-$234.85 M-29.25%
December 31, 2023
Summary
- As of February 8, 2025, DNA annual total liabilities is $568.19 million, with the most recent change of -$234.85 million (-29.25%) on December 31, 2023.
- During the last 3 years, DNA annual total liabilities has risen by +$363.09 million (+177.03%).
- DNA annual total liabilities is now -29.25% below its all-time high of $803.04 million, reached on December 31, 2022.
Performance
DNA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$682.94 M
-$109.24 M-13.79%
September 30, 2024
Summary
- As of February 8, 2025, DNA quarterly total liabilities is $682.94 million, with the most recent change of -$109.24 million (-13.79%) on September 30, 2024.
- Over the past year, DNA quarterly total liabilities has increased by +$114.75 million (+20.20%).
- DNA quarterly total liabilities is now -15.65% below its all-time high of $809.62 million, reached on March 31, 2023.
Performance
DNA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
DNA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -29.3% | +20.2% |
| 3 y3 years | +177.0% | +20.2% |
| 5 y5 years | - | - |
DNA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.3% | +12.8% | -15.7% | +59.9% |
| 5 y | 5-year | -29.3% | +177.0% | -15.7% | +233.0% |
| alltime | all time | -29.3% | +177.0% | -15.7% | +233.0% |
Ginkgo Bioworks Holdings Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $682.94 M(-13.8%) |
| Jun 2024 | - | $792.18 M(+33.3%) |
| Mar 2024 | - | $594.49 M(+4.6%) |
| Dec 2023 | $568.19 M(-29.2%) | $568.19 M(-26.6%) |
| Sep 2023 | - | $773.71 M(-1.9%) |
| Jun 2023 | - | $788.41 M(-2.6%) |
| Mar 2023 | - | $809.62 M(+0.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $803.04 M(+59.5%) | $803.04 M(+86.3%) |
| Sep 2022 | - | $430.96 M(+0.9%) |
| Jun 2022 | - | $427.16 M(-3.7%) |
| Mar 2022 | - | $443.68 M(-11.9%) |
| Dec 2021 | $503.61 M(+145.5%) | $503.61 M(-5.4%) |
| Sep 2021 | - | $532.62 M(+159.7%) |
| Dec 2020 | $205.10 M | $205.10 M |
FAQ
- What is Ginkgo Bioworks Holdings annual total liabilities?
- What is the all time high annual total liabilities for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings annual total liabilities year-on-year change?
- What is Ginkgo Bioworks Holdings quarterly total liabilities?
- What is the all time high quarterly total liabilities for Ginkgo Bioworks Holdings?
- What is Ginkgo Bioworks Holdings quarterly total liabilities year-on-year change?
What is Ginkgo Bioworks Holdings annual total liabilities?
The current annual total liabilities of DNA is $568.19 M
What is the all time high annual total liabilities for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high annual total liabilities is $803.04 M
What is Ginkgo Bioworks Holdings annual total liabilities year-on-year change?
Over the past year, DNA annual total liabilities has changed by -$234.85 M (-29.25%)
What is Ginkgo Bioworks Holdings quarterly total liabilities?
The current quarterly total liabilities of DNA is $682.94 M
What is the all time high quarterly total liabilities for Ginkgo Bioworks Holdings?
Ginkgo Bioworks Holdings all-time high quarterly total liabilities is $809.62 M
What is Ginkgo Bioworks Holdings quarterly total liabilities year-on-year change?
Over the past year, DNA quarterly total liabilities has changed by +$114.75 M (+20.20%)